Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.

Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39185396

about

The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.Ganetespib radiosensitization for liver cancer therapy EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation.eIF3i activity is critical for endothelial cells in tumor induced angiogenesis through regulating VEGFR and ERK translation.TRIP-1 via AKT modulation drives lung fibroblast/myofibroblast trans-differentiation.Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma.

P2860

Q30591171-55E1551C-35E4-4B6F-BC42-4F51F62A68BD Q35550129-BB4DD4E7-81CB-421E-AD46-189F57D83E9D Q37013260-A4E4F9F6-65F6-450C-A29F-8BC4D0EC4B81 Q37656530-AD2B0804-01DF-4208-BE0E-808034791200 Q37746206-ADF1C02E-FC4C-4BFC-BAD0-CC576EDAF9C7 Q42008055-FE50BD08-225F-4BDF-8D65-918DB57C5C38 Q42366521-18E7B0DA-940A-4C0E-8695-B3DBD463F25B Q51334042-BF1BE4B8-1E5C-4E90-931A-BE39C24318A4 Q51736289-A25AF5A9-ACF5-4EDF-8391-358F13B01577

P2860

Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39185396

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Overexpressed-eIF3I interacted ...... uman hepatocellular carcinoma.

@en

Overexpressed-eIF3I interacted ...... uman hepatocellular carcinoma.

@nl

type

label

Overexpressed-eIF3I interacted ...... uman hepatocellular carcinoma.

@en

Overexpressed-eIF3I interacted ...... uman hepatocellular carcinoma.

@nl

prefLabel

Overexpressed-eIF3I interacted ...... uman hepatocellular carcinoma.

@en

Overexpressed-eIF3I interacted ...... uman hepatocellular carcinoma.

@nl

P1433

Q39185396-F10F38B7-9585-42D9-ADC0-FBFC0191A896

P1476

Q39185396-68684E59-1B05-4E50-A045-CFE0FB5C8DAE

P2093

Q39185396-15E1A834-D342-4410-85CB-1F0E60D3E962

Q39185396-204EFA99-484C-4198-95E8-4DE6B312EE1A

Q39185396-328B2A82-ACFF-4E13-8596-1AAE51D1E71B

Q39185396-48D58A32-8A0B-4724-9615-684D6537DCF9

Q39185396-83BEE35D-F6AA-4ED6-BF54-F1A1092BF30D

Q39185396-986001C5-93B3-4080-940A-E38693D282AD

Q39185396-C74ED4C8-3A60-457C-853B-B18810A0B751

P2860

Q39185396-025C9391-1417-4266-AA4B-88BBC2898288

Q39185396-02D2C0D7-B1BA-4B97-9D4E-9B3A819206F7

Q39185396-1DF8CBF1-9CEC-4407-BEC0-BA7643D7EDE6

Q39185396-23EC6C66-F260-42FF-82FA-6D35D4C056EB

Q39185396-32E9B0CC-D8BF-4FA0-964D-67E6AFEC5634

Q39185396-40707A8F-CC98-4BEC-B44F-F78221E8F689

Q39185396-47D18100-B16E-4153-8D16-F67892E2BB4F

Q39185396-491B8785-1911-419B-A6DE-86EDE24573AD

Q39185396-4A658249-89B1-4178-9A52-4C67A5661843

Q39185396-4F9EB447-8518-48FB-A4D0-AC5DFE2AD132

P304

Q39185396-1473A7A8-2700-4BE6-9D32-231D4B14B47C

P31

Q39185396-D866218B-CF2B-4395-961D-B7F615FB1300

P356

Q39185396-E4630B31-8BE8-425E-89A5-0622C43345DF

P407

Q39185396-B0E3012A-31BC-44B9-8AE3-15EBAAD8DD85

P433

Q39185396-AC966DDF-60CF-449B-8E4D-5532FFBAEC82

P478

Q39185396-94682BC6-740C-427D-A72A-6B2DA259434D

P577

Q39185396-195C1999-E1F8-4312-8F41-508491144A2C

P698

Q39185396-44ED58FA-BA9D-4064-A6E9-DB9E31CFAFD3

P921

Q39185396-31A898A2-E098-4A96-BDCD-16A30E46888A

P356

P1433

P1476

Overexpressed-eIF3I interacted ...... uman hepatocellular carcinoma.

@en

P2093

Chian-Feng Chen

http://www.w3.org/2001/XMLSchema#string

De-Leung Gu

http://www.w3.org/2001/XMLSchema#string

Kuen-Tyng Lin

http://www.w3.org/2001/XMLSchema#string

Pang-Hsien Tu

http://www.w3.org/2001/XMLSchema#string

Shu-Chuan Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Wei Wang

http://www.w3.org/2001/XMLSchema#string

Yuh-Shan Jou

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A

Modulation of Akt kinase activity by binding to Hsp90

AKT/PKB signaling: navigating downstream

Sorafenib in advanced hepatocellular carcinoma

Regulation of translation initiation in eukaryotes: mechanisms and biological targets

Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer

A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Exploiting the PI3K/AKT pathway for cancer drug discovery

P304

239-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26352

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23460382

http://www.w3.org/2001/XMLSchema#string

P921